Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction
- PMID: 8784094
- DOI: 10.1210/jcem.81.9.8784094
Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction
Abstract
We used a recently developed ELISA format to test the hypothesis that inhibin B is the physiologically active form of inhibin in men. We measured and compared inhibin A, inhibin B, and pro-alpha-C-related immunoreactive peptides (pro-alpha-C-RI) in normal men before and after perturbations of their gonadotropin levels and baseline values in normal men and men with various disturbances of the hypothalamic-pituitary-testicular axis including men with idiopathic hypogonadotropic hypogonadism, infertile men with elevated FSH, men with Klinefelter's syndrome, and orchidectomized men. Mean serum inhibin concentrations were significantly higher in normal men than untreated men with idiopathic hypogonadotropic hypogonadism, infertile men with elevated FSH, untreated men with Klinefelter's syndrome, and orchidectomized men (187 +/- 28 vs 45 +/- 11, 37 +/- 6, 11 +/- 3, and < or = 10 pg/mL, respectively; P < 0.05). Inhibin B levels were below the limit of detection in all of the orchidectomized men. Pro-alpha-C-RI levels were detectable in all men studied including the orchidectomized men, and no significant differences in the pro-alpha-C-RI levels were noted between the normal men and men with various testicular diseases were noted except that orchidectomized men had significantly lower pro-alpha-C-RI levels than all other groups (P < 0.05). Inhibin A was undetectable in all men tested in this study. Six normal men who were administered exogenous levonorgestrel and testosterone had significantly lower serum gonadotropin, inhibin B, and pro-alpha-C-RI levels during the treatment period than the control and recovery periods (P < 0.05). Ten normal men who were administered human recombinant FSH had significantly higher peak serum FSH (21.85 +/- 3.23 IU/L vs. 3.01 +/- 0.51 IU/L), inhibin B (311 +/- 88 pg/mL vs. 151 +/- 23 pg/mL) and pro-alpha-C-RI (646 +/- 69 vs. 402 +/- 38 pg/mL) levels during the treatment period than the baseline values (P < 0.05). We conclude that inhibin B is a unique testicular product that is not detectable in the sera of orchidectomized men, is responsive to FSH stimulation, and has a reciprocal relationship with serum FSH levels in men with various forms of testicular disease. Therefore, inhibin B is likely to be the physiologically important form of inhibin in men.
Similar articles
-
Inhibin-B: a likely candidate for the physiologically important form of inhibin in men.J Clin Endocrinol Metab. 1996 Apr;81(4):1321-5. doi: 10.1210/jcem.81.4.8636325. J Clin Endocrinol Metab. 1996. PMID: 8636325
-
Serum inhibin levels in normal men and men with idiopathic infertility.Nagoya J Med Sci. 1995 Mar;58(1-2):35-9. Nagoya J Med Sci. 1995. PMID: 7659145
-
Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.J Clin Endocrinol Metab. 2000 Sep;85(9):3239-44. doi: 10.1210/jcem.85.9.6811. J Clin Endocrinol Metab. 2000. PMID: 10999815 Clinical Trial.
-
Sertoli cell markers in the diagnosis of paediatric male hypogonadism.J Pediatr Endocrinol Metab. 2012;25(1-2):3-11. doi: 10.1515/jpem-2011-0453. J Pediatr Endocrinol Metab. 2012. PMID: 22570945 Review.
-
[Inhibin B--a marker of the function of male gonad].Ginekol Pol. 2005 Jun;76(6):484-90. Ginekol Pol. 2005. PMID: 16149268 Review. Polish.
Cited by
-
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism.J Endocrinol Invest. 2009 Dec;32(11):934-8. doi: 10.1007/BF03345775. Epub 2009 Dec 1. J Endocrinol Invest. 2009. PMID: 19955846 Review.
-
Hormonal Regulation of Follicle-Stimulating Hormone Glycosylation in Males.Front Endocrinol (Lausanne). 2019 Jan 29;10:17. doi: 10.3389/fendo.2019.00017. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30761084 Free PMC article. Review.
-
Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function.Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1758-66. doi: 10.1007/s00259-009-1151-8. Epub 2009 May 27. Eur J Nucl Med Mol Imaging. 2009. PMID: 19471926 Free PMC article.
-
Biomarkers of male hypogonadism in childhood and adolescence.Adv Lab Med. 2020 Apr 21;1(2):20200024. doi: 10.1515/almed-2020-0024. eCollection 2020 Jun. Adv Lab Med. 2020. PMID: 37363780 Free PMC article. Review.
-
The Effects of Peptide Receptor Radionuclide Therapy on the Neoplastic and Normal Pituitary.Cancers (Basel). 2023 May 11;15(10):2710. doi: 10.3390/cancers15102710. Cancers (Basel). 2023. PMID: 37345047 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical